No doubt this will be an amazing listen. Huge congrats to Ian B. Hollis Doug Jennings, Pharm.D. et al for this Herculean effort. ACCP Cardiology PRN

Following VAD implantation, disturbance in patients’ bodily experience may arise. Here, women & emergent implanted patients are particularly vulnerable. Deutsches Herzzentrum der Charité 🔗: jhltonline.org/article/S1053-…

In this first report, multiorgan heart candidates who were willing to consider DCD offers had favorable waitlist outcomes with no negative impact on post-transplant outcomes. Alice Zhou Ahmet Kilic 🔗: jhltonline.org/article/S1053-…

New development in chronic #HeartTx rejection. Leukotriene B4 is a key mediator of cardiac allograft vasculopathy (CAV), the leading cause of chronic rejection. Targeting leucotriene B4 could be a novel treatment option to prevent CAV. Dong Wang 🔗 jhltonline.org/article/S1053-…

Here it is: The 2⃣nd episode of #JHLTThePodcast for August! 🫀🫁 Explore modular #simulation frameworks for #OrganTransplantation and allocation with Maryam Valapour of Cleveland Clinic and Johnie Rose of CWRU School of Medicine. 🎧 thejhlt.libsyn.com/episode-46-aug…

Discovering the limits of the possible: Two can play that game Michelle Kittleson MD PhD Yael Peled cc Sanjeeb Bhattacharya Jason F. Goldberg MD MS @ahajduczok Rachna Kataria, MD Sahar A. Saddoughi, MD, PhD Juan Fernandez 🔗: jhltonline.org/article/S1053-…

This study examines BAL positivity in lung donors and its impact on lung transplant outcomes. There is a 36% BAL positivity rate, 23% donor derived infections incidence, and worse early graft function among uncolonized recipients. @LungTxInsights 🔗: jhltonline.org/article/S1053-…

We show that the impairment of physical QoL was common in patients with CTEPH with near-normal hemodynamics; exercise capacity, hypoxemia, and hemodynamic status during exercise were related to the physical QoL. Ayumi Goda 🔗: jhltonline.org/article/S1053-…

Transplantation of hiPS-CMs is a promising therapy but with concerns of inducing unique immune responses. Our study suggests that hiPS-CMs are less immunogenic in vitro but induce CD8+ T cell immune responses in vivo. Oyama 🔗: jhltonline.org/article/S1053-…

After the centralization of heart transplant surgery in Sweden 2011, post-#HTx mortality decreased due to improved early (3-months) post-operative results. In addition, although wait time increased, wait-list survival improved. Grunde Gjesdal 🔗: jhltonline.org/article/S1053-…

NEW PUB ALERT: Our Dr. Fedson & collabs write about " The Relevance of the Ethics Statement of the ISHLT" about human organ transplantation in JHLT linkinghub.elsevier.com/retrieve/pii/S…

JHLT Grunde Gjesdal Fascinating findings! Improved early post-op results & enhanced wait-list survival underscore the importance of centralization in heart transplant surgery. Grateful for initiatives prioritizing patient care.

Our minimally invasive #LTx technique is associated with reduced hospital LOS & opioid prescription at discharge, & improved early pulmonary function over traditional approaches. Jason Thomas, Kevin (Qiudong) Chen, Pedro Catarino, @DominickMegnaMD 🔗: jhltonline.org/article/S1053-…

There were TWO episodes of #JHLTThePodcast this month—did you catch them both? 🩸 #ISHLT Consensus Statement on preventing hemocompatibility related adverse events in durable #VADs 🤖 Modular simulation frameworks for organ allocation Listen now at thejhlt.libsyn.com

Pediatric Heart Transplantation: Children living in lower 'Child Opportunity Index' zip codes had poorer waitlists and one-year post-transplant survival. 🫀 🔗: jhltonline.org/article/S1053-…

In this study focussed on PROs, authors developed 5 self-reported, reliable, 4-item short forms which may be used individually or together as a 20-item profile to assess PROs specific to adjustment & HRQOL among patients who undergo LVAD implantation 🔗: jhltonline.org/article/S1053-…

Cell-free DNA identifies episodes of Extreme Molecular Allograft Dysfunction in lung transplant patients that go on to develop allograft failure despite negative biopsy. 🫁 Dr. Agbor-Enoh Omics Lab 🔗: jhltonline.org/article/S1053-…

New #JHLT Editor-in-Chief unveils a new vision for the Journal on today's #JHLTThePodcast. Hear what Joseph Rogers, MD has to say about the opportunities facing the publication, plus some advice for prospective authors. 🎧 ishlt.org/about/news-det…

Please welcome our new Editor-in-Chief: Dr. Joseph Rogers who takes over #JHLT ranked #2 journal in transplantation, #8 in surgery, #13 in respiratory disease, and #28 in cardiovascular systems. Thank you Michelle Kittleson MD PhD for serving as the interim EIC. 🔗: jhltonline.org/article/S1053-…

Exploring the impact of comorbidities in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Insights that could reshape our approach to this high-risk population @IGIalamasMD Alexandra Arvanitaki 🔗: jhltonline.org/article/S1053-…